Gene Therapy Market Trends Report 2022-2027

1
Global Gene Therapy Market Research and Forecast
Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Gene Therapy Market Research
Report According to the latest report by IMARC
Group, titled Gene Therapy Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027, the global gene therapy
market reached a strong growth in 2021.  Gene
therapy refers to a medical technique that
involves transfer of a new healthy gene to
replace a defective gene in a cell. It aids in
preventing disease progression by manipulating
the expression of mutated genes or modifying the
biological properties of living cells for
therapeutic use. Some widely available gene
therapy products include viral and bacterial
vectors, plasmid deoxyribonucleic acid (DNA),
human gene-editing technology, and
patient-derived cellular gene therapy. Moreover,
gene therapy is rapidly gaining traction to
enhance the bodys ability to fight against
various genetic disorders and chronic diseases
that have no final cure yet. Request Free Sample
Report https//www.imarcgroup.com/gene-therapy-ma
rket/requestsample
4
Report Description and Highlights
Report Description
Global Gene Therapy Market Trends The global
gene therapy market is primarily driven by the
growing incidences of inherited and acquired
diseases, such as cancer, diabetes, cystic
fibrosis, heart disease, and acquired
immunodeficiency syndrome (AIDS). Additionally,
the rising government support and funding for
gene therapy research is another major
growth-inducing factor. Furthermore, the leading
players are developing advanced gene therapy
products that offer a safer and non-addictive
alternative to opioids in treating numerous
chronic pain conditions like lower back pain,
which is catalyzing the market growth. Other
factors, including the aging population,
increasing approvals of new gene therapy
technologies, easy access to healthcare
facilities, and technological advancements, are
also anticipated to drive the market
further. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2022-2027).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Vector Type
• Viral Vector
• Adenoviruses
• Lentiviruses
• Retroviruses
• Adeno-Associated Virus
• Herpes Simplex Virus
• Poxvirus
• Vaccinia Virus
• Others
• Non-Viral Techniques
• Naked and Plasmid Vectors
• Gene Gun
• Electroporation
• Lipofection
• Others

6
Report Description and Highlights
Report Description

• Breakup by Gene Type
• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others
• Breakup by Delivery Method
• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy
• Breakup by Application
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders

7
Report Description and Highlights
Report Description

• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia

8
Report Description and Highlights
Report Description

• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Note We are updating our reports, If you want
  latest primary and secondary data (2022-2027)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.

9
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abeona Therapeutics Inc.
• Adaptimmune Therapeutics plc
• Adverum Biotechnologies Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Bluebird Bio Inc.
• Mustang Bio Inc. (Fortress Biotech Inc.)
• Novartis AG
• Orchard Therapeutics plc
• UniQure N.V.
• Voyager Therapeutics Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/gene-therapy-market

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us